Stocks and Investing Stocks and Investing
Wed, August 14, 2024
Tue, August 13, 2024

John Newman Maintained (ATRA) at Strong Buy and Held Target at $13 on, Aug 13th, 2024


Published on 2024-10-28 13:37:11 - WOPRAI, John Newman
  Print publication without navigation


John Newman of Canaccord Genuity, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Buy and Held Target at $13 on, Aug 13th, 2024.

John has made no other calls on ATRA in the last 4 months.



There are 2 other peers that have a rating on ATRA. Out of the 2 peers that are also analyzing ATRA, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Burns of "HC Wainwright & Co." Reiterated at Hold on, Wednesday, May 22nd, 2024


This is the rating of the analyst that currently disagrees with John


  • Tommie Reerink of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $11 on, Wednesday, July 17th, 2024